BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beeharry MK, Zhang TQ, Liu WT, Gang ZZ. Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research. World J Surg Oncol 2020;18:51. [PMID: 32151257 DOI: 10.1186/s12957-020-01819-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu Q, Yang X. Comment on "Clinical pathway for enhanced recovery after surgery for gastric cancer: A prospective single-center phase II clinical trial for safety and efficacy". J Surg Oncol 2020;122:360. [PMID: 32419143 DOI: 10.1002/jso.25954] [Reference Citation Analysis]
2 Valletti M, Eshmuminov D, Gnecco N, Gutschow CA, Schneider PM, Lehmann K. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology. World J Surg Oncol 2021;19:245. [PMID: 34404403 DOI: 10.1186/s12957-021-02351-x] [Reference Citation Analysis]
3 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abdel-Rahman O. Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study. J Comp Eff Res 2021;10:1143-51. [PMID: 34515496 DOI: 10.2217/cer-2021-0113] [Reference Citation Analysis]
5 Gu Q, Wu H, Cheng Z, Zhi X, Song Q, Chen X, Yang X, Malaguarnera M. Low EBI3 Expression Promotes the Malignant Degree of Gastric Cancer. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/5588043] [Reference Citation Analysis]
6 Fu Q, Tan X, Tang H, Liu J. CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma. J Transl Med 2021;19:210. [PMID: 34001131 DOI: 10.1186/s12967-021-02806-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yago A, Haruta S, Ueno M, Ogawa Y, Shimoyama H, Ohkura Y, Udagawa H. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy. World J Surg Oncol 2022;20:35. [PMID: 35168610 DOI: 10.1186/s12957-022-02512-6] [Reference Citation Analysis]
8 Bacalbasa N, Diaconu C, Socea B, Gherghiceanu F, Savu C, Dimitriu M, Balescu I, Cordos I. Neoadjuvant intraperitoneal chemotherapy for advanced stage gastric cancer (Review). Exp Ther Med 2021;22:1314. [PMID: 34630668 DOI: 10.3892/etm.2021.10749] [Reference Citation Analysis]
9 Xu L, Liu C, Ye Z, Wu C, Ding Y, Huang J. Overexpressed LINC00467 promotes the viability and proliferation yet inhibits apoptosis of gastric cancer cells via raising ITGB3 level. Tissue Cell 2021;73:101644. [PMID: 34555778 DOI: 10.1016/j.tice.2021.101644] [Reference Citation Analysis]
10 Wang P, Zhou H, Han G, Ni Q, Dai S, Huang J, Dai C, Yu L. Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression. World J Surg Oncol 2021;19:205. [PMID: 34238296 DOI: 10.1186/s12957-021-02304-4] [Reference Citation Analysis]